Sanjay Subramanian

CIK 1790246 · SVP, CFO & Head of BD · last filed 2025-07-03

Sanjay Subramanian is a SVP, CFO & Head of BD who has filed 26 SEC Form 4 insider transactions across 2 companies since 2019. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $195.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$195.0K

Companies

2

Total Filings

26

Lifetime Open-Market Net

-$1.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Inozyme Pharma, Inc. (INZY) Delisted SVP, CFO & Head of BD 39,701 $4.00 $158.8K $100.0K 9 2025-06-27
OCGN Chief Financial Officer 161,125 $1.21 $195.0K -$1.16M 16 2022-01-05

Recent Filings

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-07-03 Mixed −39,701 -$158.8K
2025-06-27 Inozyme Pharma, Inc. (INZY) Delisted Grant (A) +6,813 $5.0K EDGAR
2025-04-02 Inozyme Pharma, Inc. (INZY) Delisted Grant (A) +2,490 $1.9K EDGAR
2025-03-17 Inozyme Pharma, Inc. (INZY) Delisted Grant (A) $0 EDGAR
2024-03-15 Inozyme Pharma, Inc. (INZY) Delisted Grant (A) $0 EDGAR
2023-10-03 Inozyme Pharma, Inc. (INZY) Delisted Grant (A) +2,319 $8.3K EDGAR
2023-04-04 Inozyme Pharma, Inc. (INZY) Delisted Grant (A) +979 $2.2K EDGAR
2023-03-27 Inozyme Pharma, Inc. (INZY) Delisted Grant (A) $0 EDGAR
2022-04-20 Inozyme Pharma, Inc. (INZY) Delisted Buy (P) +27,100 $100.0K EDGAR
2022-03-22 Inozyme Pharma, Inc. (INZY) Delisted Grant (A) $0 EDGAR
Showing 110 of 26
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.